Navigation Links
Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs
Date:12/8/2009

John L. Johnson, M.D., Professor of Medicine at Case Western Reserve University School of Medicine and pulmonologist at University Hospitals Case Medical Center has been awarded a 10 year, $19.7M contract from the U.S. Centers for Disease Control and Prevention (CDC) as an international clinical trials site for the Tuberculosis Trials Consortium (TBTC). TBTC, established in 1993, is a partnership of U.S. and international clinical investigators who conduct research about the diagnosis, medical treatment, and prevention of tuberculosis (TB) infection and disease.

As the principal investigator, Dr. Johnson will lead two research teams in the testing of new drugs and shorter and simpler regimens for the treatment of TB that will benefit patients worldwide.

Case Western Reserve School of Medicine will oversee international trial sites in Uganda and the Philippines. Roy Mugerwa, MBChB, MMed, will lead the TBTC site at the Uganda-CWRU Research Collaboration in Kampala, Uganda, globally, one of the most productive centers for TB research. The contract also supports the addition of a new trial site at the Tropical Disease Foundation in Makati City, Philippines, which will be under the direction of Thelma E. Tupasi, M.D. The two sites will enroll patients for clinical trials and substudies conducted by the TBTC; in addition to participating in working groups, committees and protocol teams of the Consortium; and other work to improve TB treatment for patients and TB control programs worldwide. Finally, Kathleen Eisenach, Ph.D., University of Arkansas for Medical Sciences, will provide microbiology consulting.

"The Case Western Reserve University School of Medicine has a long tradition of excellence in basic, translational and clinical research in tuberculosis and has been at the forefront of international TB research for more than two decades. My lifetime research goal is to shorten the duration of anti-TB treatment required to treat most patients," says Dr. Johnson, who is also a Professor of International Health. "This CDC contract funds TB researchers at Case Western Reserve to continue our work in conducting clinical trials to improve treatment."

According to the World Health Organization, more than nine million people around the world become sick with TB, and almost one million to two million die each year. In some areas, the disease is epidemic, with hundreds of thousands affected in nations such as China, India, and Vietnam, and in many countries of sub-Saharan Africa.

Tuberculosis is a communicable disease that can be fatal if not treated. TB usually affects the lungs, but can also affect other parts of the body, such as the brain, kidneys, or spine. New, more effective drugs and regimens for persons afflicted with TB are needed since treatment with currently available drugs requires at least six months of therapy. In addition, new drugs are urgently needed to treat patients with multi-(MDR) and extensively drug resistant (XDR)-TB, where TB germs are resistant to two or more of the best drugs currently used to treat the disease.


'/>"/>

Contact: Jessica Studeny
jessica.studeny@case.edu
216-368-4692
Case Western Reserve University
Source:Eurekalert

Related medicine news :

1. Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies
2. Case Western Reserve researchers new pathway discovery published as Paper of the Week
3. Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk
4. Western diets turn on fat genes
5. Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find
6. Holistic and Western Medicine Combined Can Fight Cancer
7. UT Southwestern receives continued NIH funding for Inner City Asthma Consortium
8. Case Western School of Medicine receives RWJF grant to establish a public health research network
9. Finding Ways for Disabled People to Participate in Research is Goal of Case Western Reserve University Nursing School Study
10. Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region
11. Case Western Reserve University receives $20.5 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Valley, CA (PRWEB) , ... December 07, 2016 , ... ... be used in several ways to restore a more youthful appearance to the face. ... now offer Sculptra, along with a variety of other treatments, to rejuvenate and renew ...
(Date:12/7/2016)... ... ... time to blow out his candles on his 14th birthday, Estefano Reano had only one ... at Joe DiMaggio Children’s Hospital surprised his family with a phone call that made his ... “He was playing at home, when we got the phone call telling us there was ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... planning services to families and business owners in the greater Dallas metropolitan area, ... the Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals ...
(Date:12/7/2016)... ... XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s ... Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition similar ... the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... LONDON , Dec. 7, 2016 ... Global Market Intelligence (2011-2020)" provides market intelligence on ... and forecast (2011-2020) has been provided in the ... to provide 1) comprehensive global market intelligence through ... rates, market dynamics, industry structure and developments, market ...
(Date:12/7/2016)... Dec. 7, 2016  Northwest Biotherapeutics (Nasdaq: ... a biotechnology company developing DCVax® personalized immune therapies ... Nasdaq Staff has not accepted the Company,s plan ... previously reported, and the Company has notified Nasdaq ... common stock from listing on Nasdaq.  Upon withdrawal ...
(Date:12/7/2016)... Hoovers Research analysis is one ... combinational analytical tools. The report contains up to ... to present unique and reliable analysis. Assessment of ... during the next five years, including a deep ... sub markets, regional and country level analysis. The ...
Breaking Medicine Technology: